In short
This article explores the use of Indometacin Ph. Eur. in clinical trials, specifically focusing on its role in the treatment of Langerhans Cell Histiocytosis (LCH) in children and adolescents. The LCH-IV trial, an international collaborative study, aims to improve treatment outcomes and reduce long-term complications for patients with this rare condition. We'll discuss the trial's objectives, eligibility criteria, and the potential benefits of using Indometacin as part of the treatment protocol.
At a glance
- Trial Name
- LCH-IV International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis
- Trial Category
- Therapeutic exploratory and confirmatory clinical trial (Phase II and III integrated)
- Medical Condition
- Langerhans Cell Histiocytosis
- Main Objectives
- Reduce mortality in multi-system LCH, investigate continuation therapy options, reduce reactivation rates and late sequelae
- Indometacin Ph. Eur. Role
- Used in continuation therapy, compared to 6-MP/MTX for 24 months total treatment
- Dosage
- Maximum daily dose: 2 mg/kg, Maximum total dose: 1120 mg/kg
- Administration Route
- Oral
- Treatment Duration
- Up to 80 weeks
- Primary Endpoints
- Reactivation-free survival, overall and disease-free survival, neurodegenerative CNS-LCH progression, response of CNS lesions, rate of permanent consequences
- Key Eligibility Criteria
- Histologically verified LCH diagnosis, no prior systemic therapy, signed informed consent
What is INDOMETACIN PH. EUR.?
INDOMETACIN PH. EUR. is an active substance used in medicine. It's also known by its generic name, indomethacin. This drug is available in the form of hard capsules, specifically as INDOMETACIN CAPSULES BP 25mg. Indometacin belongs to a class of medications called non-steroidal anti-inflammatory drugs (NSAIDs), which are known for their anti-inflammatory properties.
Medical Uses
Indometacin is primarily used as an anti-inflammatory medication. It can help in treating various conditions characterized by pain, swelling, and inflammation. While the specific clinical trial data provided doesn't detail all its uses, generally, indometacin is prescribed for:
- Arthritis and joint pain
- Muscle aches and pains
- Headaches
- Menstrual cramps
In the context of the clinical trial mentioned, indometacin is being studied as part of a treatment protocol for Langerhans Cell Histiocytosis (LCH), a rare disorder that can affect children and adolescents.
Dosage and Administration
According to the clinical trial information, the following dosage details are provided for INDOMETACIN PH. EUR.:
- The maximum daily dose is 2 mg/kg (milligrams per kilogram of body weight).
- The maximum total dose amount is 1120 mg/kg.
- The maximum treatment period is 80 weeks.
It's important to note that this dosage information is specific to the clinical trial and may not reflect the typical dosage for other conditions. Always follow your doctor's instructions regarding dosage and duration of treatment.
Role in Langerhans Cell Histiocytosis (LCH) Treatment
The clinical trial data suggests that INDOMETACIN PH. EUR. is being studied as part of a treatment protocol for Langerhans Cell Histiocytosis (LCH) in children and adolescents. LCH is a rare disorder where certain immune system cells (called Langerhans cells) grow and multiply excessively, causing damage to various parts of the body.
In this trial, indometacin is being investigated as part of a continuation therapy. Specifically, it's being compared to other medications (6-MP/MTX) for a 24-month continuation therapy in patients with non-risk organ involvement. This is part of a broader study aiming to improve treatment outcomes for LCH patients.
Important Considerations
While INDOMETACIN PH. EUR. can be an effective medication, there are several important points to keep in mind:
- Prescription Only: This medication is only available with a doctor's prescription. Never use it without proper medical supervision.
- Administration Route: INDOMETACIN PH. EUR. is taken orally in the form of capsules.
- Not for All Ages: The clinical trial data doesn't indicate that this is a pediatric formulation, so its use in children should be carefully considered by healthcare professionals.
- Potential Side Effects: As with all medications, indometacin can cause side effects. Always discuss potential risks and benefits with your healthcare provider.
- Ongoing Research: The use of indometacin in LCH treatment is part of ongoing research. Its effectiveness and safety in this context are still being studied.
Remember, this information is based on clinical trial data and may not represent all uses or considerations for INDOMETACIN PH. EUR. Always consult with your healthcare provider for personalized medical advice and before starting or changing any medication regimen.